Zhao et al demonstrated HOXA‐AS2 could up‐regulate HOXA3, thereby activating the EGFR/Ras/Raf/MEK/ERK signalling pathway and decreased glucocorticoid sensitivity in acute lymphoblastic leukaemia.17 Here, MAP2K7 is linked to acute lymphoblastic leukemia.